Skip to content
Investor login
logo
  • About us
    • About Coller Capital
    • Our people
    • Responsible business
    • Responsible investment
    • Responsible leadership
  • Our strategies
    • Overview
    • Private capital secondaries
    • Private credit secondaries
    • Our funds
    • Individual investments
  • Our industry
  • Responsible investment
  • News & insights
  • Coller Research Institute
  • Careers
AtomInvest
Fundraising data room
Sungard
Current CIP Investors
Corpro
Current CCO Investors
  • About us
    • About Coller Capital
    • Our people
    • Responsible business
    • Responsible investment
    • Responsible leadership
  • Our strategies
    • Overview
    • Private capital secondaries
    • Private credit secondaries
    • Our funds
    • Individual investments
  • Our industry
  • Responsible investment
  • News & insights
  • Coller Research Institute
  • Careers
Investor login
AtomInvest
Fundraising data room
Sungard
Current CIP Investors
Corpro
Current CCO Investors

Share

In July 2022, CIP VIII co-lead the largest GP-led transaction in Asia with Hahn & Company for SsangYong C&E, closing at approximately $1.5bn. Coller Capital and its co-investors  were the single largest investors.

13 July 2022
Article
Back to all news
Close Icon for closig the QR code QR code Coller Wechat for chatting with the team of Coller Capital

Coller research publications

The Coller Research Institute produces, sponsors and disseminates high quality research into all aspects of private equity.
Subscribe to receive the Global Private Equity Barometer, ESG Report, Private Equity Findings and other publications.
Popular links
  • Our strategies
  • News & insights
  • Responsible investment
  • Careers
  • Contact & offices
  • Terms & Conditions
  • Privacy Notice & Cookie Policy
  • Social Media Disclosures
  • Accessibility policy
  • UK Modern Slavery Act
  • ESG Policy
  • Sitemap
  • Cyber security
© Coller Capital . | Website design and build by SoBold
Coller Capital Limited is registered in England and Wales (registered number: 3020017), with a registered office at Park House, 116 Park Street, London, W1K 6AF, United Kingdom